Randy Byron

Metronomic Therapy Shows Promise in Breast Cancer

January 10, 2025

TOPLINE:Metronomic capecitabine combined with an aromatase inhibitor extends median progression-free survival to 2src.9 months compared with 11.9 months for aromatase...

Randy Byron

Metronomic Therapy Shows Promise in Breast Cancer

Estranged Boyfriend Charged in ‘Extreme’ Death of Utah Woman Found in Cardboard Box

Salmonella, illegal sweeteners spark FDA to increase import enforcement

High Dose Atropine Curbs Myopia in Kids Despite Side Effects

Metronomic Therapy Shows Promise in Breast Cancer

AGA Issues Guidance on Using P-CABs

The FDA is urging these brands of ground cinnamon products to issue voluntary recalls

Timothée Chalamet Was Told He Was Too Skinny to Be a Movie Star

KFF Health News Sues To Force Disclosure of Medicare Advantage Audit Records

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

Gender-Affirming Care Isn’t Just for Adults, Say AMA Delegates

Estranged Boyfriend Charged in ‘Extreme’ Death of Utah Woman Found in Cardboard Box

Salmonella, illegal sweeteners spark FDA to increase import enforcement

High Dose Atropine Curbs Myopia in Kids Despite Side Effects

Metronomic Therapy Shows Promise in Breast Cancer

AGA Issues Guidance on Using P-CABs

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories